CircCDC6, a tumor suppressor, was downregulated in CRC patient tumor tissues, where it inhibited tumor growth and glycolytic metabolism in CRC via the mir-3187-3p/PRKAA2 axis27. Here, PRKAA2 is linked to neoplasm.